Dr Jon Eric Binkerd, MD, | |
1911 Lay Dam Rd, Clanton, AL 35045-8351 | |
(205) 280-3248 | |
(205) 280-3369 |
Full Name | Dr Jon Eric Binkerd |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 17 Years |
Location | 1911 Lay Dam Rd, Clanton, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962685545 | NPI | - | NPPES |
149637 | Medicaid | AL | |
R9469 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 31935 (Alabama) | Secondary |
207Q00000X | Family Medicine | MD.31935 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Vincent's Chilton | Clanton, AL | Hospital |
Elmore Community Hospital | Wetumpka, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Chilton Surgical Associates | 0446490536 | 2 |
News Archive
The Avicena Group has announced today that the United States Food and Drug Administration (FDA) has granted orphan drug designation to HD-02, the company's proprietary drug candidate for the treatment of Huntington's disease.
Bayer Schering Pharma AG and OncoMed Pharmaceuticals, Inc., today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
The drug combination indacaterol/glycopyrronium (trade name: Ultibro Breezhaler, Xoterna Breezhaler) has been approved since September 2013 for adults with chronic obstructive pulmonary disease (COPD).
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
› Verified 9 days ago
Entity Name | Chilton Surgical Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912342205 PECOS PAC ID: 0446490536 Enrollment ID: O20130715000144 |
News Archive
The Avicena Group has announced today that the United States Food and Drug Administration (FDA) has granted orphan drug designation to HD-02, the company's proprietary drug candidate for the treatment of Huntington's disease.
Bayer Schering Pharma AG and OncoMed Pharmaceuticals, Inc., today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
The drug combination indacaterol/glycopyrronium (trade name: Ultibro Breezhaler, Xoterna Breezhaler) has been approved since September 2013 for adults with chronic obstructive pulmonary disease (COPD).
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jon Eric Binkerd, MD, 1911 Lay Dam Rd, Clanton, AL 35045-8351 Ph: (205) 280-3248 | Dr Jon Eric Binkerd, MD, 1911 Lay Dam Rd, Clanton, AL 35045-8351 Ph: (205) 280-3248 |
News Archive
The Avicena Group has announced today that the United States Food and Drug Administration (FDA) has granted orphan drug designation to HD-02, the company's proprietary drug candidate for the treatment of Huntington's disease.
Bayer Schering Pharma AG and OncoMed Pharmaceuticals, Inc., today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
The drug combination indacaterol/glycopyrronium (trade name: Ultibro Breezhaler, Xoterna Breezhaler) has been approved since September 2013 for adults with chronic obstructive pulmonary disease (COPD).
The University of Michigan's second human embryonic stem cell line has just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the second of the stem cell lines derived at U-M to be placed on the registry.
› Verified 9 days ago
Dr. Jeffrey F Price, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 Health Center Dr, Clanton, AL 35045 Phone: 205-280-1010 Fax: 205-280-3744 | |
April Nicole Jones, CRNP Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Medical Center Dr, Clanton, AL 35045 Phone: 205-755-4960 | |
Mr. Charles Keith Funderburk, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 108 Medical Center Dr, Clanton, AL 35045 Phone: 205-755-5700 Fax: 205-755-4966 | |
Miss Toshia Nicole Milam, CRNP MSN, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 108 Medical Center Dr, Clanton, AL 35045 Phone: 205-755-5700 | |
Kent Johns, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 Hinkle Rd, Clanton, AL 35045 Phone: 205-755-3799 | |
Ms. Isabella Childress Hudson, CRNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 108 Medical Center Dr, Clanton, AL 35045 Phone: 205-755-5700 |